Lanreotide is used to treat persistently low blood sugar levels (hypoglycaemia) caused by the body producing too much insulin (hyperinsulinism). This information from Great Ormond Street Hospital (GOSH) describes lanreotide injections, how they are given and some of its side effects.
X-linked lymphoproliferative type 1 (XLP1) disorder is a rare immune condition that affects around 1 in every 1 million males.This page has been produced jointly between PID UK, Great Ormond Street Hospital (GOSH) and the Great North Children’s Hospital.
This leaflet is designed to help answer the questions families may have about the immune condition called combined immunodeficiency (CID). It has been produced jointly by PID UK and the paediatric immunodeficiency centres at Great Ormond Street Hospital (GOSH) and the Great North Children’s Hospital.
This information sheet explains the first phase of the assessment process to diagnose lower gastrointestinal dysmotility problems and what to expect when your child comes to Great Ormond Street Hospital (GOSH) for assessment.